The Rational Design of Drugs with Phos-phonic/phinic Acids as Enzyme Inhibitors Isosteric Receptor Ligands

Author： Ebetino Frank H.   Soper David L.   Dirr Michelle J.   Lundy Mark W.   Mieling Glen   Wos John A.   deLong Mitchell A.   Liu Xuewei  

Publisher： Taylor & Francis Ltd

ISSN： 1042-6507

Source： Phosphorus, Sulfur, and Silicon and the Related Elements, Vol.177, Iss.6-7, 2002-06, pp. : 1725-1729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synkem will license SynPhos ligands

By  

Focus on Catalysts, Vol. 2003, Iss. 5, 2003-05 ,pp. : 5-5

Elsevier

Access to resources Recommend Favorite

Rational Drug Design Paradigms: The Odyssey for Designing Better Drugs

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 18, Iss. 3, 2015-01 ,pp. : 238-256

Bentham Science Publishers

Access to resources Recommend Favorite

Rational questing for inhibitors of endothelin converting enzyme-1 from Salvia miltiorrhiza by combining ligand- and structure-based virtual screening

By Xiang Yuhong  

Canadian Journal of Chemistry, Vol. 91, Iss. 6, 2013-03 ,pp. : 448-456

NRC Research Press

Access to resources Recommend Favorite

Rational Polytherapy with Antiepileptic Drugs

By Lee Jong Woo   Dworetzky Barbara  

Pharmaceuticals, Vol. 3, Iss. 8, 2010-07 ,pp. : 2362-2379

MDPI

Access to resources Recommend Favorite

The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design

By Cozza Giorgio  

Pharmaceuticals, Vol. 10, Iss. 1, 2017-02 ,pp. : 26-26

MDPI

Access to resources Recommend Favorite